menu ☰
menu ˟

Post-surgical chemotherapy versus surgery alone for resectable gastric cancer

Creator:

Diaz-Nieto, R., et al

Subject Keywords: To determine whether post-surgical chemotherapy should be used routinely in resectable gastric cancer
Set: Cancer
Chronic Conditions
Conditions
Type: Article
Region: International (other)
Description:

Stomach cancer is the second leading cause of cancer-related death worldwide. Surgery is the only curative treatment offered to patients suffering from this cancer. Survival rates, however, are still poor. Chemotherapy given after surgery has been developed in order to improve these results. We identified 34 trials with 7824 patients which randomised patients to surgery with post-surgical chemotherapy versus surgery alone. The group who received chemotherapy had a survival benefit and improvement in disease free survival (15% and 21%, respectively), although all the trials had a high risk of bias. There was no significant difference due to the stage of disease or the chemotherapy agent used.

Date:

02/09/2013

Rights: © The Cochrane Collaboration
Suggested citation:

Diaz-Nieto, R., et al. (2013) Post-surgical chemotherapy versus surgery alone for resectable gastric cancer [Online]. Available from: http://www.thehealthwell.info/node/570021 [Accessed: 23rd January 2018].

  

View your saved citations and reading lists

Contributor:

Other partner websites
 
Click here to view all the resources gathered from this organisation's website.

IPH Logo